Garcia, D. & Erkan, D. Diagnosis and management of the antiphospholipid syndrome. N. Engl. J. Med. 378, 2010–2021 (2018).
Article CAS PubMed Google Scholar
Knight, J. S., Branch, D. W. & Ortel, T. L. Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management. BMJ 380, e069717 (2023).
Andreoli, L. et al. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Arthritis Care Res. 65, 1869–1873 (2013).
Sciascia, S. et al. The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review. Ann. Rheum. Dis. 74, 2028–2033 (2015).
Article CAS PubMed Google Scholar
Duarte-Garcia, A. et al. The epidemiology of antiphospholipid syndrome: a population-based study. Arthritis Rheumatol. 71, 1545–1552 (2019).
Article CAS PubMed PubMed Central Google Scholar
Ioannou, Y., Beukelman, T., Murray, M. & Erkan, D. Incidence of antiphospholipid syndrome: is estimation currently possible? Eur. J. Rheumatol. 10, 39–44 (2023).
Article PubMed PubMed Central Google Scholar
Taraborelli, M. et al. The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus. Lupus 25, 1365–1368 (2016).
Article CAS PubMed Google Scholar
Barbhaiya, M. et al. Efforts to better characterize “Antiphospholipid Antibody Nephropathy” for the 2023 ACR/EULAR antiphospholipid syndrome classification criteria: renal pathology subcommittee report. J. Rheumatol. 51, 150–159 (2024).
Crowther, M. et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N. Engl. J. Med. 18, 1133–1138 (2003).
Finazzi, G. et al. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J. Thromb. Haemost. 3, 848–853 (2005).
Article CAS PubMed Google Scholar
Barbhaiya, M. et al. 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Arthritis Rheumatol. 75, 1687–1702 (2023).
Chayoua, W. et al. Antiprothrombin antibodies induce platelet activation: a possible explanation for anti-FXa therapy failure in patients with antiphospholipid syndrome? J. Thromb. Haemost. 19, 1776–1782 (2021).
Article CAS PubMed PubMed Central Google Scholar
Müller-Calleja, N. et al. Lipid presentation by the protein C receptor links coagulation with autoimmunity. Science 12, eabc0956 (2021).
Ruben, E. et al. The J-elongated conformation of β2-glycoprotein I predominates in solution: implications for our understanding of antiphospholipid syndrome. J. Biol. Chem. 295, 10794–10806 (2020).
Article CAS PubMed PubMed Central Google Scholar
Kumar, S., Wulf, J. III, Basore, K. & Pozzi, N. Structural analyses of β2-glycoprotein I: is there a circular conformation? J. Thromb. Haemost. 21, 3511–3521 (2023).
Canaud, G. et al. Inhibition of the mTORC pathway in the antiphospholipid syndrome. N. Engl. J. Med. 371, 303–312 (2014).
Ramesh, S. et al. Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2. J. Clin. Invest. 121, 120–131 (2011).
Article CAS PubMed Google Scholar
Canaud, G., Legendre, C. & Terzi, F. AKT/mTORC pathway in antiphospholipid-related vasculopathy: a new player in the game. Lupus 24, 227–230 (2015).
Article CAS PubMed Google Scholar
Long, B. R. & Leya, F. The role of antiphospholipid syndrome in cardiovascular disease. Hematol. Oncol. Clin. North. Am. 22, 79–94 (2008).
Alarcon-Segovia, D., Cardiel, M. H. & Reyes, E. Antiphospholipid arterial vasculopathy. J. Rheumatol. 16, 762–767 (1989).
Hughson, M. D., McCarty, G. A. & Brumback, R. A. Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome. Hum. Pathol. 26, 716–724 (1995).
Article CAS PubMed Google Scholar
Dorland, W. Dorland’s Illustrated Medical Dictionary 32nd edn (Saunders/Elsevier, 2012).
Calvo, F., Karras, B. T., Phillips, R., Kimball, A. M. & Wolf, F. Diagnoses, syndromes, and diseases: a knowledge representation problem. AMIA Annu. Symp. Proc. 2003, 802 (2003).
PubMed PubMed Central Google Scholar
Martirosyan, A., Aminov, R. & Manukyan, G. Environmental triggers of autoreactive responses: induction of antiphospholipid antibody formation. Front. Immunol. 10, 1609 (2019).
Article CAS PubMed PubMed Central Google Scholar
Willis, R., Harris, E. N. & Pierangeli, S. S. Pathogenesis of the antiphospholipid syndrome. Semin. Thromb. Hemost. 38, 305–321 (2012).
Article CAS PubMed Google Scholar
Aggarwal, R. et al. Distinctions between diagnostic and classification criteria? Arthritis Care Res. 67, 891–897 (2015).
Wilson, W. A. et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 42, 1309–1311 (1999).
Article CAS PubMed Google Scholar
Miyakis, S. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J. Thromb. Haemost. 4, 295–306 (2006).
Article CAS PubMed Google Scholar
Barbhaiya, M. et al. Development of a new international antiphospholipid syndrome classification criteria phase I/II report: generation and reduction of candidate criteria. Arthritis Care Res. 73, 1490–1501 (2021).
Kelchtermans, H., Pelkmans, L., de Laat, B. & Devreese, K. M. IgG/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis. J. Thromb. Haemost. 14, 1530–1548 (2016).
Article CAS PubMed Google Scholar
Chayoua, W. et al. The (non-)sense of detecting anti-cardiolipin and anti-β2glycoprotein I IgM antibodies in the antiphospholipid syndrome. J. Thromb. Haemost. 18, 169–179 (2020).
Article CAS PubMed Google Scholar
Galli, M. & Barbui, T. Antiphospholipid antibodies and thrombosis: strength of association. Hematol. J. 4, 180–186 (2003).
Article CAS PubMed Google Scholar
Brusch, A., Bundell, C. & Hollingsworth, P. Immunoglobulin G is the only anti-beta-2-glycoprotein I isotype that associates with unprovoked thrombotic events among hospital patients. Pathology 46, 234–239 (2014).
Article CAS PubMed Google Scholar
Zuo, Y. et al. Prevalence of antiphospholipid antibodies and association with incident cardiovascular events. JAMA Netw. Open. 6, e236530 (2023).
Article PubMed PubMed Central Google Scholar
Cuadrado, M. J. et al. Can anticoagulation be withdrawn in APS patients after aPL negativization? Autoimmun. Rev. https://doi.org/10.1016/j.autrev.2023.103427 (2023).
Erkan, D. et al. Real-world experience with antiphospholipid antibody tests: how stable are results over time? Ann. Rheum. Dis. 64, 1321–1325 (2005).
Article CAS PubMed PubMed Central Google Scholar
Vandevelde, A. et al. Semiquantitative interpretation of anticardiolipin and antiβ2glycoprotein I antibodies measured with various analytical platforms: communication from the ISTH SSC subcommittee on lupus anticoagulant/antiphospholipid antibodies. J. Thromb. Haemost. 20, 508–524 (2022).
Article CAS PubMed Google Scholar
Erkan, D. et al. Response to: correspondence on ‘2023 ACR/EULAR antiphospholipid syndrome classification criteria’ by Miro-Mur et al. Ann Rheum Dis. 83, e3 (2024).
van den Hoogen, F. et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 65, 2737–2747 (2013).
Article PubMed PubMed Central Google Scholar
Lundberg, I. E. et al. 2017 European League Against Rheumatism/American College of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol. 69, 2271–2282 (2017).
Article PubMed PubMed Central Google Scholar
Roubey, R. A., Eisenberg, R. A., Harper, M. F. & Winfield, J. B. “Anticardiolipin” autoantibodies recognize beta 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding. J. Immunol. 154, 954–960 (1995).
留言 (0)